Literature DB >> 3377643

Plasma homovanillic acid as a predictor of response to neuroleptics.

R Davila1, E Manero, M Zumarraga, I Andia, J W Schweitzer, A J Friedhoff.   

Abstract

Fourteen schizophrenic subjects were evaluated for degree of psychosis before and after treatment with the antipsychotic drug haloperidol and for plasma homovanillic acid concentration after four and 28 days of treatment. A significant correlation was found between an increase in homovanillic acid concentration on day 4 or a decrease from day 4 to day 28 and the degree of improvement after four weeks of treatment. Thus, those patients who had the greatest change in plasma homovanillic acid in response to neuroleptic blockade showed the greatest improvement. These and other observations have led us to propose that the central dopaminergic system, through adaptive changes in activity, serves as a physiologic buffer system protecting against destabilization of mental function from diverse biologic or psychologic insults.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377643     DOI: 10.1001/archpsyc.1988.01800300060007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  16 in total

1.  Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.

Authors:  J A Den Boer; D P Ravelli; J Huisman; J Ohrvik; W M Verhoeven; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

3.  Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.

Authors:  J G Csernansky; E P Bellows; D E Barnes; L Lombrozo
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Reducing ability of the striatum and cerebral cortex in rats following acute administration of risperidone or haloperidol: an estimation by in vivo electron paramagnetic resonance imaging.

Authors:  Hidekatsu Yokoyama; Osamu Itoh; Hiroaki Ohya-Nishiguchi; Hitoshi Kamada
Journal:  Neurochem Res       Date:  2002-03       Impact factor: 3.996

5.  GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.

Authors:  Aurora Arrúe; Ricardo Dávila; Mercedes Zumárraga; Nieves Basterreche; Miguel A González-Torres; Biotza Goienetxea; Maria I Zamalloa; Juan B Anguiano; José Guimón
Journal:  Neurochem Res       Date:  2009-08-22       Impact factor: 3.996

6.  Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

Authors:  A Wolkin; E Duncan; M Sanfilipo; S Wieland; T B Cooper; J Rotrosen
Journal:  J Neural Transm Gen Sect       Date:  1994

7.  Plasma homovanillic acid and prolactin in Huntington's disease.

Authors:  Manolis Markianos; Marios Panas; Nikos Kalfakis; Dimitrios Vassilopoulos
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

8.  Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  On the selection of mice for haloperidol response and non-response.

Authors:  R Hitzemann; K Dains; C M Bier-Langing; N R Zahniser
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics.

Authors:  J G Csernansky; J W Newcomer; K Jackson; L Lombrozo; K F Faull; R Zipursky; A Pfefferbaum; W O Faustman
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.